Ribociclib
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Ribociclib is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
Ribociclib is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $289.72 to $346.95 per EA — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$289.72 – $346.95
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing RIBOCICLIB
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
KISQALI 400 MG DAILY DOSE | $346.9469 per EA | — |
KISQALI 600 MG DAILY DOSE | $289.7167 per EA | — |
Frequently Asked Questions
What is Ribociclib used to treat?
Ribociclib is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.
How many Ribociclib products are on the market?
The Ribociclib drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Ribociclib?
NADAC reference prices for Ribociclib range from $289.7167 to $346.9469 per EA — a 20% difference between cheapest and most expensive.
Which manufacturers make Ribociclib?
1 manufacturer lists Ribociclib in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (2).